Clinical Trials Logo

Hereditary Ataxia clinical trials

View clinical trials related to Hereditary Ataxia.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04750850 Completed - Cerebellar Ataxia Clinical Trials

Core Stability Exercises and Hereditary Ataxia

Core-ataxia
Start date: May 20, 2021
Phase: N/A
Study type: Interventional

The hereditary ataxias are a group of genetic disorders characterized by slowly progressive incoordination of gait and balance impairments in sitting and standing. Trunk local stability during gait is lower in patients with degenerative ataxia than that in healthy adult population. Given the fact that drug interventions are rare in degenerative diseases and limited to only specific type of diseases and symptoms, physiotherapy is a major cornerstone in current therapy of ataxic gait. Core stability exercises training could be included as an adjunct to conventional balance training in improving dynamic balance and gait. Due to the nature of the interventions, the study will have a single blind design.

NCT ID: NCT00202397 Completed - Multiple Sclerosis Clinical Trials

Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia

Start date: June 2005
Phase: Phase 2
Study type: Interventional

Cerebellar disorders are often disabling and symptomatic therapies are limited to few options that are partially effective. It seems therefore appropriate to search for additional approaches. Purkinje cells are the sole output of the cerebellar cortex: they project inhibitory signals to the deep cerebellar nuclei (DCN), which have a critical role in cerebellar function and motor performance. DCN neurons fire spontaneously in the absence of synaptic input from Purkinje neurons and modulation of the DCN response by Purkinje input is believed to be responsible for coordination of movement. Recent evidences support the notion that an increase in DCN excitability may be an important step in the development of cerebellar ataxia and point to the underlying molecular mechanisms: the inhibition of small-conductance calcium-activated potassium (SK) channels, that causes an increase of the firing frequency in DCN, correlates with cerebellar ataxia. The rationale of the present project is that SK channel openers, such as riluzole, may have a beneficial effect on cerebellar ataxia. The researchers propose to perform a pilot study investigating safety and efficacy of riluzole, an approved treatment for amyotrophic lateral sclerosis, as a symptomatic approach in patients with chronic cerebellar ataxia.

NCT ID: NCT00004306 Completed - Hereditary Ataxia Clinical Trials

Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)

Start date: November 1999
Phase: N/A
Study type: Observational

OBJECTIVES: I. Clinically evaluate members from families with a dominantly inherited ataxia and collect blood, skin and muscle samples for detailed molecular studies. II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.